The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Androgen Treatment of Abdominally Obese Men
Open accessAbstract
Middle‐aged men with abdominal obesity were treated in a double‐blind study with moderate doses of transdermal preparations of testosterone (T), dihydrotestosterone (DHT), or placebo. This resulted in moderately elevated T concentrations and marked decreases in follicle stimulating and luteinizing hormones in the group treated with T, while the DHT group showed elevated DHT, markedly lower T values, and less diminution of gonadotropin concentrations. In the group treated with T visceral fat mass decreased (measured by computerized tomography) without significant changes in other depot fat regions. Lean body mass did not change. In the group treated with T, glucose disposal rate, measured with the euglycemic hyperinsulinemic clamp method, was markedly augmented. Plasma triglycerides, cholesterol, and fasting blood glucose concentrations as well as diastolic blood pressure decreased. There were no such changes in the DHT or placebo treatment groups. The men treated with T reported increased well‐being and energy. In none of the groups did prostate volume, specific prostate antigen concentration, genitourinary history, or urinary flow measurement change. It is suggested that supplementation of abdominal obese men with moderate doses of T might have several beneficial effects. (OBESITY RESEARCH 1993;1:245–251)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The decrease in serum triglycerides follows a similar pattern: after 4 weeks (38), after 3 months (35), and with further decrease over 9 months (41) or 12 months (43).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [41]
In the citing paper
“In some studies a decline in diastolic blood pressure has been observed, after 3–9 months (22, 35, 41, 44) and in some studies in systolic blood pressure also (35, 44).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Kvist, H., Chowdhury, B., Grangård, U., Tylén, U., & Sjöström, L. (1988) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/48.6.1351 · Cited by 794
Self-citationSeidell, J. C., Björntorp, P., Sjöström, L., Kvist, H., & Sannerstedt, R. (1990) · Metabolism · doi:10.1016/0026-0495(90)90297-p · Cited by 567
Self-citationThe effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
Mårin, P., Holmäng, S., Jönsson, L., Sjöström, L., Kvist, H., Holm, G., Lindstedt, G., & Björntorp, P. A. (1992) · PubMed · Cited by 553
Self-citationVague, P., Juhan-Vague, I., Aillaud, M. F., Badier, C., Viard, R., Alessi, M., & Collen, D. (1986) · Metabolism · doi:10.1016/0026-0495(86)90209-x · Cited by 443
Percutaneous Absorption of Steroids*
Scheuplein, R. J., Blank, I. H., Brauner, G., & Macfarlane, D. J. (1969) · Journal of Investigative Dermatology · doi:10.1038/jid.1969.9 · Cited by 392
Testosterone: A Major Determinant of Extragenital Sexual Dimorphism
Bardin, C. W., & Catterall, J. F. (1981) · Science · doi:10.1126/science.7010603 · Cited by 381
Estimation of Total Body Fat from Potassium-40 Content
Forbes, G. B., Gallup, J., & Hursh, J. B. (1961) · Science · doi:10.1126/science.133.3446.101 · Cited by 341
Abdominal obesity and the development of noninsulin‐dependent diabetes mellitus
Björntorp, P. A. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040607 · Cited by 292
Self-citationEffect of testosterone on abdominal adipose tissue in men.
Rebuffé-Scrive, M., Mårin, P., & Björntorp, P. A. (1991) · PubMed · Cited by 223
Self-citation
Research works printed but not linked: 2
- Arvidsson B., 1972, Clinical applications of a high‐sensitivity whole‐body counter, Digest of the Third International Conference on Medical Engineering. Gothenburg, 41, 2
- WHO, 1988, Measuring obesity; classification and description of anthropometric data. Report on a WHO consultation on the epidemiology of obesity. EURMFA target 16. Regional office in Europe, 1
Cited by
Sorted by citations
Items 201–300 of 345
Visceral obesity and the role of the somatotropic axis in the development of metabolic complications
Franco, C., Bengtsson, B., & Johannsson, G. (2001) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(01)80016-2 · Cited by 22
Venkatesh, V. S., Grossmann, M., Zajac, J. D., & Davey, R. A. (2022) · Obesity Reviews · doi:10.1111/obr.13429 · Cited by 22
Rosenblatt, A., Faintuch, J., & Cecconello, I. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1663-1 · Cited by 21
Visceral Obesity and the Metabolic Syndrome
Rosmond, R. (2001) · Wiley eBooks · doi:10.1002/0470846739.ch23 · Cited by 21
Xu, L., & Schooling, C. M. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12862 · Cited by 20
Testosterone as a marker of coronary artery disease severity in middle aged males
Gururani, K., Jose, J., & George, P. V. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2016.07.002 · Cited by 20
The effect of glucocorticoids on fat and lean tissue masses in giant cell arteritis
Nordborg, C. (1998) · Scandinavian Journal of Rheumatology · doi:10.1080/030097498440967 · Cited by 20
Abdelhamed, A., Hisasue, S., Shirai, M., Matsushita, K., Wakumoto, Y., Tsujimura, A., Tsukamoto, T., & Horie, S. (2015) · Research and Reports in Urology · doi:10.2147/rru.s72253 · Cited by 19
Thiruppathi, M., Palaniappan, M., Srinivasan, C., & Balasubramanian, K. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0737-1 · Cited by 18
Nieschlag, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5060-7 · Cited by 18
Svensson, J., Bengtsson, B. ‐., Taskinen, M., Wiklund, O., & Johannsson, G. (2000) · Growth Hormone & IGF Research · doi:10.1054/ghir.2000.0148 · Cited by 18
Physiological Responses to Agonist–Antagonist Superset Resistance Training
Fink, J. E., Schoenfeld, B. J., Sakamaki‐Sunaga, M., & Nakazato, K. (2020) · Journal of Science in Sport and Exercise · doi:10.1007/s42978-020-00092-z · Cited by 18
Aydoğdu, A., Bolu, E., Sönmez, A., Taşçı, İ., Haymana, C., Acar, R., Meriç, C., Taşlıpınar, A., Özgürtaş, T., & Azal, Ö. (2012) · Clinical Endocrinology · doi:10.1111/cen.12135 · Cited by 17
Sattler, F. R. (2014) · Journal of Gerontology & Geriatric Research · doi:10.4172/2167-7182.1000159 · Cited by 18
Perusquı́a, M., Contreras, D., & Herrera, N. (2019) · Endocrine · doi:10.1007/s12020-019-01978-x · Cited by 19
Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy
Deepika, F., Ballato, E., Colleluori, G., Aguirre, L. E., Chen, R., Qualls, C., Villareal, D. T., & Armamento‐Villareal, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.915309 · Cited by 19
Kumagai, H., Miyaki, A., Higashino, R., Akazawa, N., Choi, Y., Ra, S., Eto, M., Tanaka, K., Ajisaka, R., & Maeda, S. (2014) · Artery Research · doi:10.1016/j.artres.2014.04.003 · Cited by 15
The Significance of Low Testosterone Levels in Obese Men
Pelusi, C., & Pasquali, R. (2012) · Current Obesity Reports · doi:10.1007/s13679-012-0029-4 · Cited by 16
Androgen Effect on Insulin Action and Glucose Metabolism
Rizza, R. A. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(19)30645-7 · Cited by 16
Modern, new pharmacotherapy for obesity. A gastrointestinal approach
Gaal, L. V., Mertens, I. L., Ballaux, D., & Verkade, H. J. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.09.001 · Cited by 14
Visceral obesity, androgens and the risks of cardiovascular disease and diabetes mellitus
Gooren, L. J. (2001) · The Aging Male · doi:10.1080/tam.4.1.30.38 · Cited by 15
Testosterone and Atherosclerosis Progression in Men
Bhasin, S., & Herbst, K. L. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1929 · Cited by 14
Androgen Effect on Body Composition and Fat Metabolism
Jensen, M. D. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(19)30646-9 · Cited by 14
Foulkes, S., Daly, R. M., & Fraser, S. F. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0505 · Cited by 13
Testosterone, obesity, diabetes and the metabolic syndrome
Jones, T. H., & Channer, K. S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.012 · Cited by 13
Testosterone and the metabolic syndrome
Arver, S. (2008) · Journal of Men s Health · doi:10.1016/j.jomh.2008.03.009 · Cited by 13
Yamamoto, S., Arakaki, R., Noguchi, H., Takeda, A., Uchishiba, M., Kamada, S., Mineda, A., Kon, M., Kawakita, T., Kinouchi, R., et al. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114199 · Cited by 12
Vlachopoulos, C. V., Pietri, P., Ioakeimidis, N., Aggelis, A., Terentes-Printzios, D. G., Abdelrasoul, M., Gourgouli, I., Stefanadis, C., & Tousoulis, D. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.04.018 · Cited by 12
Hackett, G. I. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02922.x · Cited by 13
Management of cardiovascular complications in Klinefelter syndrome patients
Accardo, G., Paglionico, V. A., Fraia, R. D., Cittadini, A., Salzano, A., Espósito, D., Bellis, A. D., & Pasquali, D. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1584036 · Cited by 11
Hormonal regulation of visceraladipose tissue
Björntorp, P. A. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80020-8 · Cited by 12
Self-citationBody mass index, waist/hip ratio and androgen—estrogen activity in youngerversusolder Polish men
Jankowska, E. W. A., Mędraś, M., & Rogucka, E. (2000) · The Aging Male · doi:10.1080/13685530008500366 · Cited by 11
Effects of androgens in men with the metabolic syndrome
Mårin, P. (1998) · The Aging Male · doi:10.3109/13685539809148611 · Cited by 12
Self-citationYu, G. W., & Traish, A. M. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2011.131 · Cited by 11
Consensus Document on substitution therapy with testosterone in hypoandrogenic elderly men
Valenti, G. (2002) · Aging Clinical and Experimental Research · doi:10.1007/bf03327345 · Cited by 11
Testosterone supplementation: why and for whom?
Gooren, L. J. (2003) · The Aging Male · doi:10.1080/tam.6.3.184.199 · Cited by 11
Testosterone Therapy for Prevention and Treatment of Obesity in Men
Caliber, M., & Saad, F. (2020) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2020.0010 · Cited by 11
Jabaloyas, J. M. M., Zaragoza, A., Cortés, C., Zaragozá, J. A. Q., Salom, M. G., & Nuez, P. C. (2008) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(08)73895-6 · Cited by 11
The Impact of Testosterone on Erectile Function
Schardein, J. N., & Hotaling, J. M. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0033 · Cited by 10
Ukkola, O. H., Huttunen, T., Puurunen, V.-P., Piira, O.-P., Niva, J., Lepojärvi, S., Tulppo, M. P., & Huikuri, H. V. (2013) · Annals of Medicine · doi:10.3109/07853890.2012.711951 · Cited by 9
Sex Differences in Obesity-Related Glucose Intolerance and Insulin Resistance
Shi, H., & Kumar, S. P. D. S. (2012) · InTech eBooks · doi:10.5772/52972 · Cited by 11
Growth Hormone Secretion after Testosterone Administration to Men with Visceral Obesity
Mårin, P., Rosmond, R., Bengtsson, B., Gustafsson, C., Holm, G., & Bjömtorp, P. (1994) · Obesity Research · doi:10.1002/j.1550-8528.1994.tb00056.x · Cited by 9
Self-citationAndrogens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-388-7:191 · Cited by 13
Androgen deficiency in the aging male: When to evaluate and when to treat
Nolten, W. E. (2000) · Current Urology Reports · doi:10.1007/s11934-000-0013-5 · Cited by 9
Son, D., Kwon, Y., & Lee, J. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2024.100270 · Cited by 8
Liu, R., Zhou, J., Xia, S., & Li, T. (2019) · Urologia Internationalis · doi:10.1159/000503906 · Cited by 8
The relationship between testosterone and metabolic syndrome
Kawano, H. (2010) · Hypertension Research · doi:10.1038/hr.2010.52 · Cited by 8
Effects of varying doses of testosterone on atherogenic markers in healthy younger and older men
Roberts, C. K., Chen, B. H., Pruthi, S., & Lee, M. L. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00372.2013 · Cited by 8
Testosterone in men's health: a new role for an old hormone
Feeley, R. J., Saad, F., Guay, A. T., & Traish, A. M. (2009) · Journal of Men s Health · doi:10.1016/j.jomh.2009.06.005 · Cited by 8
Williams, B. R., & Cho, J. S. (2017) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.04.006 · Cited by 7
Tae, B. S., Jeon, B. J., Choi, H., Bae, J. H., & Park, J. Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2325 · Cited by 7
Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism)
Saad, F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_23 · Cited by 6
V. The Effects of Aging and Testosterone on Lipids and Cardiovascular Risk
Bagatell, C. J., & Bremner, W. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5060-5 · Cited by 7
Fan, H., Wang, Y., He, W., Zhou, H., & Yang, T. (2022) · Clinical Endocrinology · doi:10.1111/cen.14829 · Cited by 6
Risks and benefits of hormone replacement therapy in older men
Pasqualotto, F. F., Lucón, A. M., Hallak, J., Pasqualotto, E. B., & Arap, S. (2004) · Revista do Hospital das Clínicas · doi:10.1590/s0041-87812004000100006 · Cited by 7
Hormones, Body Composition and Cardiovascular Risk
Sjöström, L., Alpsten, M., Andersson, B., Bengtsson, B., Bengtsson, C., Björntorp, P. A., Bosaeus, I. G., Brummer, R. J., Chowdhury, B., Edén, S., et al. (1993) · Springer eBooks · doi:10.1007/978-1-4899-1268-8_54 · Cited by 6
Self-citationTestosterone Deficiency: A Common, Unrecognised Syndrome?
Schulman, C. C., Fusco, F., Morales, A. M., Tostain, J., Vendeira, P., & Zitzmann, M. (2009) · European Urology Supplements · doi:10.1016/j.eursup.2009.05.003 · Cited by 6
Testosterone Supplementation for Hypogonadal Impotence
Morales, Á., Johnston, B., Heaton, J. P. W., & Lundie, M. J. (1997) · The Journal of Urology · doi:10.1097/00005392-199703000-00027 · Cited by 6
Tenover, J. L. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-388-0_18 · Cited by 6
Pal, P., Maranon, R. O., Gonzales, O. J. R., Speed, J. S., & Janorkar, A. V. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112249 · Cited by 5
Cardiopulmonary fitness but not muscular fitness associated with visceral adipose tissue mass
An, K., Kim, S., Oh, M., Lee, H. S., Yang, H. I., Park, H., Lee, J., & Jeon, J. Y. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1628066 · Cited by 5
Wpływ testosteronowej terapii zastępczej na stężenia witaminy D i FGF-23 w hipogonadyzmie wrodzonym
Haymana, C., Sönmez, A., Aydoğdu, A., Tapan, S., Başaran, Y., Meriç, C., Başköy, K., Taşlıpınar, A., Yılmaz, M. İ., & Azal, Ö. (2017) · Endokrynologia Polska · doi:10.5603/ep.a2017.0009 · Cited by 5
Testosterone and cardiovascular disease
Channer, K. S., & Jones, T. H. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.011 · Cited by 5
Gambineri, A., Pelusi, C., Vicennati, V., Pagotto, U., & Pasquali, R. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.3.477 · Cited by 5
Metabolic Syndrome and Hypogonadism
Wespes, E. (2013) · European Urology Supplements · doi:10.1016/j.eursup.2013.03.003 · Cited by 5
Björntorp, P. A. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00122-6 · Cited by 5
Self-citationImportancia clínica, métodos diagnósticos y efectos del ejercicio físico sobre la grasa visceral
Vázquez, R. F., Correas-Gómez, L., Carnero, E. Á., & Alvero‐Cruz, J. R. (2014) · Archivos de medicina del deporte: revista de la Federación Española de Medicina del Deporte y de la Confederación Iberoamericana de Medicina del Deporte · Cited by 4
Obesity’s role in secondary male hypogonadism: a review of pathophysiology and management issues
Seyam, O., Gandhi, J., Joshi, G. S., Smith, N. L., & Khan, S. A. (2019) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-019-00056-7 · Cited by 5
High Prevalence of Y Chromosome Partial Microdeletions in Overweight Men.
Biabangard-Zak, A., Golalipour, M., & Hadadchi, G. (2015) · Europe PMC (PubMed Central) · Cited by 4
Pharmacological treatment of obesity
Salvador, J., Silva, C., & Santos, E. (2009) · Anales del Sistema Sanitario de Navarra · doi:10.23938/assn.0822 · Cited by 4
Androgens and Body Fat Distribution in Men
Pi-Sunyer, X. (1993) · Obesity Research · doi:10.1002/j.1550-8528.1993.tb00625.x · Cited by 4
Gooren, L. J. (2008) · Journal of Men s Health · doi:10.1016/j.jomh.2008.04.002 · Cited by 4
Youssef, M., Saleh, N., mohamed, A. E.-H., & Khatib, Y. A. E. (2010) · AUSTRALIAN JOURNAL OF BASIC AND APPLIED SCIENCES · Cited by 4
Effect of Androgen Deficiency on the Condition of Carbohydrate Metabolism in Men
Mkrtumyan, A. M., Yegshatyan, L. V., & Shishkova, Y. A. (2020) · Effective Pharmacotherapy · doi:10.33978/2307-3586-2020-16-12-56-66 · Cited by 4
Johannsson, G., Mårin, P., Johansson, P., & Bengtsson, B. Å. (2000) · doi:10.1007/978-1-59259-015-5_15 · Cited by 4
Self-citationHypogonadism: cardiometabolism and gonadal function in men
Noble, M., & Cahill, D. J. (2023) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2023.58 · Cited by 3
Pharmacologic Therapy of Obesity
Bray, G. A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-694-2_16 · Cited by 3
Influence of Dietary Supplements on Body Composition
Friedl, K. E. (2017) · CRC Press eBooks · doi:10.1201/9781351260008-16 · Cited by 3
Therapeutic Dilemmas for Androgen Deficiency in Aging Males
Salazar, J. A., & Tan, R. S. (2005) · Aging Health · doi:10.2217/1745509x.1.1.157 · Cited by 3
[Age-related androgen deficiency: diagnostic work-up].
Rossi, D., & Tostain, J.-B. (2004) · PubMed · Cited by 3
Testosterone and the Older Man
Tenover, J. L. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-700-0_18 · Cited by 3
Commentary: Androgen replacement therapy in the aging male--a critical evaluation.
Vermeulen, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · Cited by 3
Dhindsa, S., Ghanim, H., & Dandona, P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00265 · Cited by 3
Testosterone and the Metabolic Syndrome in Men: Current Knowledge
Nieschlag, E., & Zitzmann, M. (2006) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 3
Déficit androgénique: effet de la substitution sur la composition corporelle
Kuhn, J. (2002) · Andrologie · doi:10.1007/bf03034944 · Cited by 3
Effect of real-world androgen abuse on body composition: a prospective cohort study
Verdegaal, T. J., Bond, P., de Ronde, W., & Smit, D. L. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag142 · Cited by 2
Unlocking the therapeutic potential and personalized therapy of testosterone: a comprehensive review
Reddy, A. V., Ramasamy, K., Rajendran, P., & Deva, R. (2024) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2024-0035 · Cited by 2
HRT for the Aging Male: A Therapy That Has Come of Age?
Tenover, J. L. (2000) · Springer eBooks · doi:10.1007/978-1-4612-2106-7_8 · Cited by 2
II. Changes in Reproductive Hormones During the Aging Process
Bagatell, C. J., & Bremner, W. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5060-2 · Cited by 2
Tenover, J. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3439 · Cited by 2
[Androgens and prostate: basic research and clinical data].
Pm, M., Rossi, D., Muracciole, X., SAUSSINE, C., Raynaud, J., & Tostain, J.-B. (2004) · PubMed · Cited by 2
A Study of Serum Total Testosterone Levels in Type 2 Diabetes Mellitus Male Patients
Trivedi, J., & Kapoor, S. (2017) · Annals of International medical and Dental Research · doi:10.21276/aimdr.2017.3.4.bc1 · Cited by 2
Tenover, J. L. (2007) · Springer eBooks · doi:10.1007/978-0-585-38145-9_7 · Cited by 2
Watve, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4409-1_11 · Cited by 2
Testosterone replacement and cardiovascular disease risk
Gonzalez, J. R., & Goldstein, I. (2015) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000051 · Cited by 2
Androgens in Aging Men: Do Men Benefit from Testosterone Replacement?
Bagatell, C. J., & Bremner, W. J. (1998) · Rejuvenation Research · doi:10.1089/rej.1.1998.1.359 · Cited by 2
VI. A Pragmatic Approach to Androgen Replacement in Older Men: Risks vs. Benefits
Korenman, S. G. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5060-6 · Cited by 2
Hormonersatztherapie beim Mann - Sinn oder Unsinn?
Jockenhövel, F., & Schubert, M. (2003) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2
A Case for Drug Treatment of Obesity
Bray, G. A. (1994) · Hospital Practice · doi:10.1080/21548331.1994.11443089 · Cited by 2
Verze, P., & Mirone, V. G. (2011) · Springer eBooks · doi:10.1007/978-1-84882-034-0_17 · Cited by 2
Metadata
- Authors
- Mårin, P., Holmtäng, S., Gustafsson, C., Jönsson, ‡., Kvist, ‡., Elander, A., Eldh, J., Sjöström, L., Holm, G., & Björntorp, P.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Corresponding author
- Mårin, Per
- Venue
- Obesity Research
- Publisher
- Wiley
- Published
- 1993-07
- Volume
- 1
- Issue
- 4
- Pages
- 245-251
- ISSN
- 1071-7323 (ISSN-L)
- 1550-8528
- OpenAlex
- W2009810419
- Cited by
- 345
- References
- 19
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 8 · 2019: 9 · 2018: 10 · 2017: 14 · 2016: 8 · 2015: 17 · 2014: 18 · 2013: 18 · 2012: 19
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Obesity Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- androgen therapy, abdominal obesity, testosterone, dihydrotestosterone, visceral fat, glucose disposal, insulin sensitivity, gonadotropins, blood pressure, lipid profile, middle-aged men, prostate volume
- MeSH terms
- Adult, Aged, Androgens, Blood Glucose, Blood Pressure, Body Composition, Body Weight, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Type 2, Double-Blind Method, Glucose, Gonadotropins, Humans, Male, Middle Aged, Obesity, Placebos, Risk Factors, Sex Hormone-Binding Globulin, Dihydrotestosterone, Testosterone, Time Factors, Tomography, X-Ray Computed, Triglycerides, Prostate-Specific Antigen, Abdominal Fat, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review